BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21986254)

  • 1. Pyrazinamide-induced anaphylaxis: diagnosed by skin test and successful desensitization.
    Bavbek S; Yılmaz I; Aydın Ö; Ozdemir SK
    Int Arch Allergy Immunol; 2012; 157(2):209-12. PubMed ID: 21986254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral desensitization to antitubercular agents].
    Drira I; Souissi R; Dakhlaoui R; Jeguirim MS; Chebbi ML
    Rev Pneumol Clin; 1997; 53(2):104-6. PubMed ID: 9205691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status quo of pyrazinamide as an antituberculosis drug].
    Kameda K
    Kekkaku; 1995 Jul; 70(7):445-55. PubMed ID: 7564054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylaxis to rifampicin and pyrazinamide in a child with tuberculous meningitis: A case report.
    Nadri G; Taneja S; Singh V; Mittal P
    Indian J Tuberc; 2017 Apr; 64(2):144-146. PubMed ID: 28410699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
    Ban GY; Jeong YJ; Lee SH; Shin SS; Shin YS; Park HS; Kim SH; Ye YM
    Respir Med; 2019 Feb; 147():44-50. PubMed ID: 30704698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent dysosmia induced by pyrazinamide.
    El Aïdli S; Kastalli S; Zaïem A; Lakhoua G; Rejeibi I; Loueslati MH; Daghfous R; Belkahia C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):539-41. PubMed ID: 19674115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C; Nicopoulos C; Vassiliou M; Manda-Stachouli C; Sakellariou K; Demou GS; Constantopoulos SH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):675-8. PubMed ID: 9712283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylaxis to omeprazole: diagnosis and desensitization protocol.
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):33-6. PubMed ID: 16440530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tuberculosis chemotherapy and management of adverse reactions].
    Kuwabara K
    Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
    Garca-Doval I
    J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid-induced anaphylaxis.
    Crook MJ
    J Clin Pharmacol; 2003 May; 43(5):545-6. PubMed ID: 12751276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
    Dixit R; Sharma S; Nawal CL
    J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Allergy to antitubercular agents; with special reference to new drugs].
    Mühlberger F
    Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096
    [No Abstract]   [Full Text] [Related]  

  • 15. [First-time standard setting for therapy of pulmonary tuberculosis after revision of the Medical Treatment Standard--special reference to results of questionnaire survey on reality of early stage short-term PZA therapy and occurrence of the adverse effects].
    Kekkaku; 1997 Nov; 72(11):639-42. PubMed ID: 9463114
    [No Abstract]   [Full Text] [Related]  

  • 16. Management and successful desensitization in methotrexate-induced anaphylaxis.
    Bouchireb K; Dodille A; Ponvert C; Gouraud F; Dubrel M; Brugières L
    Pediatr Blood Cancer; 2009 Feb; 52(2):295-7. PubMed ID: 18855892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of antituberculosis drugs.
    Mohan A; Sharma SK
    Am J Respir Crit Care Med; 2004 Apr; 169(7):882-3. PubMed ID: 15044223
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
    Fernández-Solà J; Campistol JM; Miró O; Garcés N; Soy D; Grau JM
    Nephrol Dial Transplant; 1996 Sep; 11(9):1850-2. PubMed ID: 8918638
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps.
    Gupta S; Gupta V; Kapoor B; Kapoor V
    J Indian Med Assoc; 2007 Jun; 105(6):341-2. PubMed ID: 18232182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazinamide induced photoallergy.
    Maurya V; Panjabi C; Shah A
    Int J Tuberc Lung Dis; 2001 Nov; 5(11):1075-6. PubMed ID: 11716347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.